Robert J. Hugin

2014

In 2014, Robert J. Hugin earned a total compensation of $24.2M as CEO and Chairman at Celgene, a 15% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$9,110,269
Option Awards$9,614,448
Salary$1,380,000
Stock Awards$3,899,980
Other$231,416
Total$24,236,113

Hugin received $9.6M in option awards, accounting for 40% of the total pay in 2014.

Hugin also received $9.1M in non-equity incentive plan, $1.4M in salary, $3.9M in stock awards and $231.4K in other compensation.

Rankings

In 2014, Robert J. Hugin's compensation ranked 86th out of 13,032 executives tracked by ExecPay. In other words, Hugin earned more than 99.3% of executives.

ClassificationRankingPercentile
All
86
out of 13,032
99th
Division
Manufacturing
35
out of 4,966
99th
Major group
Chemicals And Allied Products
15
out of 1,686
99th
Industry group
Drugs
14
out of 1,365
99th
Industry
Pharmaceutical Preparations
14
out of 1,043
99th
Source: SEC filing on April 28, 2016.

Hugin's colleagues

We found six more compensation records of executives who worked with Robert J. Hugin at Celgene in 2014.

2014

Peter Kellogg

Celgene

Chief Financial Officer

2014

Jacqualyn Fouse

Celgene

President Hematology and Oncology

2014

Mark Alles

Celgene

Chief Operating Officer

2014

Thomas Daniel

Celgene

Chairman

2014

Perry Karsen

Celgene

Chief Executive Officer

2014

Scott Smith

Celgene

President, Immunology & Inflammation

You may also like